tiprankstipranks
Advertisement
Advertisement
Guardian Pharmacy affirms FY26 revenue view of $1.40B-$1.42B, consensus $1.42B
PremiumThe FlyGuardian Pharmacy affirms FY26 revenue view of $1.40B-$1.42B, consensus $1.42B
15d ago
Guardian Pharmacy initiated with a Buy at BofA
Premium
The Fly
Guardian Pharmacy initiated with a Buy at BofA
24d ago
Guardian Pharmacy price target raised to $43 from $38 at Truist
Premium
The Fly
Guardian Pharmacy price target raised to $43 from $38 at Truist
1M ago
Guardian Pharmacy 6M share Spot Secondary priced at $31.00
PremiumThe FlyGuardian Pharmacy 6M share Spot Secondary priced at $31.00
2M ago
Guardian Pharmacy prices 6M shares at $31.00 in upsized public offering
Premium
The Fly
Guardian Pharmacy prices 6M shares at $31.00 in upsized public offering
2M ago
Guardian Pharmacy secondary offering; price range $30.60-$31.60
Premium
The Fly
Guardian Pharmacy secondary offering; price range $30.60-$31.60
2M ago
Guardian Pharmacy Services Posts Strong Growth Amid Headwinds
PremiumCompany AnnouncementsGuardian Pharmacy Services Posts Strong Growth Amid Headwinds
2M ago
Guardian Pharmacy reports Q4 EPS 37c, consensus 27c
Premium
The Fly
Guardian Pharmacy reports Q4 EPS 37c, consensus 27c
2M ago
Guardian Pharmacy backs FY26 revenue view of $1.40B-$1.42B, consensus $1.42B
Premium
The Fly
Guardian Pharmacy backs FY26 revenue view of $1.40B-$1.42B, consensus $1.42B
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100